AwardedSpainGoods
Suministro de medicamentos biológicos originales y biosimilares basadas en los principios activos adalimumab, trastuzumab, etanercept, rituximab, infliximab y bevacizumab para el Hospital Universitario Miguel Servet de Zaragoza
- Published
- Published 8 April 2025
Overview
Suministro de medicamentos biológicos originales y biosimilares basadas en los principios activos adalimumab, trastuzumab, etanercept, rituximab, infliximab y bevacizumab para el Hospital Universitario Miguel Servet de Zaragoza
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Procedure
- Selective
- Published
- 8 April 2025
Pharmaceutical products
Award outcome
- Awarded value
- €346,792
- Award date
- 4 April 2025
- ABBVIE SPAIN, S.L.U
- AMGEN S.A.
- BIOGEN SPAIN S.L
- ORGANON SALUD, S.L.,
- PFIZER SLU
- SANDOZ FARMACEUTICA, SA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
8 April 2025
Contracting authority
Gerencia Sector Sanitario de Zaragoza 2
Procuring entityZaragoza, Spain
ID_PLATAFORMA: 20997630143523
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.